Gulf Coast Veterinary Oncology Revenue and Competitors
Estimated Revenue & Valuation
- Gulf Coast Veterinary Oncology's estimated annual revenue is currently $15M per year.
- Gulf Coast Veterinary Oncology's estimated revenue per employee is $68,493
Employee Data
- Gulf Coast Veterinary Oncology has 219 Employees.
- Gulf Coast Veterinary Oncology grew their employee count by 8% last year.
Gulf Coast Veterinary Oncology's People
Name | Title | Email/Phone |
---|---|---|
1 | Client Experience Manager | Reveal Email/Phone |
2 | Human Resources Manager | Reveal Email/Phone |
3 | Ancillary Services Manager | Reveal Email/Phone |
4 | Chairman the Board, Gulf Coast Veterinary Specialists, Board Directors Compassion-First | Reveal Email/Phone |
5 | Sonographer/ MRI technologist | Reveal Email/Phone |
6 | Accounts Receivable Specialist | Reveal Email/Phone |
7 | Veterinary Assistant | Reveal Email/Phone |
8 | OR Technician-LVT | Reveal Email/Phone |
9 | Diagnostic Imaging Supervisor | Reveal Email/Phone |
10 | Emergency Department Lead | Reveal Email/Phone |
Gulf Coast Veterinary Oncology Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3.5M | 62 | 24% | N/A | N/A |
#2 | $3.5M | 46 | 15% | N/A | N/A |
#3 | $35M | 125 | -13% | N/A | N/A |
#4 | $3.5M | 46 | 24% | N/A | N/A |
#5 | N/A | 29 | 7% | N/A | N/A |
#6 | $3.5M | 42 | 2% | N/A | N/A |
#7 | $7.5M | 155 | 5% | N/A | N/A |
#8 | $15M | 350 | 6% | N/A | N/A |
#9 | N/A | 32 | 7% | N/A | N/A |
#10 | $7.5M | 91 | -3% | N/A | N/A |
What Is Gulf Coast Veterinary Oncology?
Healthcare & Pharmaceuticals
keywords:N/AN/A
Total Funding
219
Number of Employees
$15M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $28.9M | 219 | 2% | N/A |
#2 | $28.9M | 219 | 30% | N/A |
#3 | $59.3M | 220 | 4% | N/A |
#4 | $78.2M | 220 | 7% | N/A |
#5 | N/A | 220 | 17% | N/A |